Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $912000.0.

  • Burning Rock Biotech's Other Non-Current Assets fell 3415.16% to $912000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $912000.0, marking a year-over-year decrease of 3415.16%. This contributed to the annual value of $1.1 million for FY2024, which is 5125.35% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Other Non-Current Assets is $912000.0, which was down 3415.16% from $926000.0 recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Other Non-Current Assets ranged from a high of $8.3 million in Q4 2021 and a low of $500000.0 during Q1 2024
  • Over the past 5 years, Burning Rock Biotech's median Other Non-Current Assets value was $1.6 million (recorded in 2023), while the average stood at $2.6 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 19142.86% in 2021, then tumbled by 7629.58% in 2023.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Other Non-Current Assets stood at $8.3 million in 2021, then crashed by 63.71% to $3.0 million in 2022, then crashed by 76.3% to $718000.0 in 2023, then surged by 51.25% to $1.1 million in 2024, then decreased by 16.02% to $912000.0 in 2025.
  • Its last three reported values are $912000.0 in Q3 2025, $926000.0 for Q2 2025, and $1.1 million during Q1 2025.